Value of pulmonary arterial hypertension in predicting survival after cardiac resynchronization therapy

Jingfeng Wang,Shengmei Qin,Yangang Su,Haiyan Chen,Jin Bai,Wei Wang,Junbo Ge
DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2014.02.012
2014-01-01
Abstract:Objective To investigate the usefulness of elevated systolic pulmonary artery pressure ( SPAP ) to predict clinical outcome in patients receiving cardiac resynchronization therapy ( CRT ) . Methods The present study retrospectively analyzed data from 165 subjects undergoing CRT,who were strati-fied into two groups according to echocardiographic assessments of SPAP (107 cases with SPAP<50 mmHg and 58 cases with SPAP≥50 mmHg) . The primary endpoint of all-cause mortality and secondary endpoint of heart failure rehospitalization were compared between the two groups using Kaplan-Meier method. Cox regression mod-els were also run for both end points. Results Thirteen (22. 4%) patients died and 25 (43. 1%) were read-mitted for heart failure in patients with SPAP≥50 mmHg,with a significantly higher incidence than subjects with SPAP<50 mmHg,among whom 8 (7. 5%) patients died and 21(19. 6%) were rehospitalized (P<0. 01 for both) . Compared with SPAP<50 mmHg,those with SPAP≥50 mmHg had significantly shorter survival ( P<0. 05) and higher occurrence of readmission for heart failure (P<0. 01) based on Kaplan-Meier analysis. In a multivariate model,subjects with SPAP≥50 mmHg were significantly more likely to reach both primary end-point (hazard ratio 3. 089,95% confidence interval 1. 117 to 8. 543,P=0. 03) and secondary endpoint (hazard ratio 2. 465,95% confidence interval 1. 318 to 4. 611,P=0. 005). Conclusion In patients receiving CRT,an elevated baseline SPAP is associated with adverse clinical outcome and is an independent predictor of all-cause mortality and heart failure readmission.
What problem does this paper attempt to address?